HEALTHCARE
CREATING
A GLOBAL
FOOTPRINT:
TARGETING
PRESSING
PUBLIC HEALTH
NEEDS
The scientifi c community has
made signifi cant progress in eff orts
to extend and enhance human health.
By developing treatments and vaccines
to reduce the burden of some of the
most debilitating diseases of our time,
we have dramatically improved health
outcomes for people worldwide.
Despite such progress, critical
challenges remain, such as persistent
infectious disease threats that put at risk
hundreds of millions of people globally,
coupled with an unprecedented rise
of non-communicable diseases and
chronic conditions. We continue to
see new outbreaks that threaten human
well-being, such as the emergence and
amplifi cation of global pandemics in
the form of the Ebola and Zika viruses.
Moreover, the upsurge of antibiotic
resistance, deemed one of the greatest
public health emergencies of our time
by the World Health Organization (WHO),
is also undermining the painstaking
progress we have made.
To eff ectively tackle such an array of
global public health challenges, we must
continually explore new ways to develop
novel drugs, diagnostics, and partnerships
that ensure vulnerable communities have
access to essential tools that will keep
98
them healthy. Actors across sectors must
work together to leverage the strengths
and expertise of their unique perspectives
and ca pabilities. Shared goals require
shared plans of attack to combat diseases
that continue to threaten the well-being
of vulnerable populations.
At Johnson & Johnson and its Janssen
Pharmaceutical Companies, we are
committed to protecting the health of
people today and for generations to come.
Thoughtful collaborations that spur on-
going innovation are critical to this end.
Putting innovation at the core of our
R&D strategy propels our activities
in the laboratory, and inspires novel
collaborations with the world’s best
scientists and entrepreneurs. Through
partnerships with leading organizations in
science and policy, we aim to accelerate
innovation around the world as well